Literature DB >> 34932957

FiberSim: A flexible open-source model of myofilament-level contraction.

Sarah Kosta1, Dylan Colli2, Qiang Ye3, Kenneth S Campbell2.   

Abstract

FiberSim is a flexible open-source model of myofilament-level contraction. The code uses a spatially explicit technique, meaning that it tracks the position and status of each contractile molecule within the lattice framework. This allows the model to simulate some of the mechanical effects modulated by myosin-binding protein C, as well as the dose dependence of myotropes and the effects of varying isoform expression levels. This paper provides a short introduction to FiberSim and presents simulations of tension-pCa curves with and without regulation of thick and thin filament activation by myosin-binding protein C. A myotrope dose-dependent response as well as slack/re-stretch maneuvers to assess rates of tension recovery are also presented. The software was designed to be flexible (the user can define their own model and/or protocol) and computationally efficient (simulations can be performed on a regular laptop). We hope that other investigators will use FiberSim to explore myofilament level mechanisms and to accelerate research focusing on the contractile properties of sarcomeres.
Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34932957      PMCID: PMC8790209          DOI: 10.1016/j.bpj.2021.12.021

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  26 in total

1.  Theoretical formalism for the sliding filament model of contraction of striated muscle. Part II.

Authors:  T L Hill
Journal:  Prog Biophys Mol Biol       Date:  1975       Impact factor: 3.667

2.  Filament compliance effects can explain tension overshoots during force development.

Authors:  Kenneth S Campbell
Journal:  Biophys J       Date:  2006-09-01       Impact factor: 4.033

3.  Compliant realignment of binding sites in muscle: transient behavior and mechanical tuning.

Authors:  T L Daniel; A C Trimble; P B Chase
Journal:  Biophys J       Date:  1998-04       Impact factor: 4.033

4.  Muscle activation described with a differential equation model for large ensembles of locally coupled molecular motors.

Authors:  Sam Walcott
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2014-10-16

5.  A small-molecule modulator of cardiac myosin acts on multiple stages of the myosin chemomechanical cycle.

Authors:  Raja F Kawas; Robert L Anderson; Sadie R Bartholomew Ingle; Yonghong Song; Arvinder S Sran; Hector M Rodriguez
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

6.  Effects of mavacamten on Ca2+ sensitivity of contraction as sarcomere length varied in human myocardium.

Authors:  Peter O Awinda; Yemeserach Bishaw; Marissa Watanabe; Maya A Guglin; Kenneth S Campbell; Bertrand C W Tanner
Journal:  Br J Pharmacol       Date:  2020-10-21       Impact factor: 8.739

7.  Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes.

Authors:  James W McNamara; Amy Li; Nicola J Smith; Sean Lal; Robert M Graham; Kristina Bezold Kooiker; Sabine J van Dijk; Cristobal G Dos Remedios; Samantha P Harris; Roger Cooke
Journal:  J Mol Cell Cardiol       Date:  2016-03-26       Impact factor: 5.000

8.  Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments.

Authors:  Thomas Kampourakis; Yin-Biao Sun; Malcolm Irving
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 9.  Small Molecules acting on Myofilaments as Treatments for Heart and Skeletal Muscle Diseases.

Authors:  Khulud Alsulami; Steven Marston
Journal:  Int J Mol Sci       Date:  2020-12-16       Impact factor: 5.923

10.  Sarcomere lattice geometry influences cooperative myosin binding in muscle.

Authors:  Bertrand C W Tanner; Thomas L Daniel; Michael Regnier
Journal:  PLoS Comput Biol       Date:  2007-07       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.